Transcatheter heart valve interventions: where are we? Where are we going?-Reference-Cited by-同舟云学术

Transcatheter heart valve interventions: where are we? Where are we going?

Published:2019-01-04 Issue:5 Volume:40 Page:422-440
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Prendergast Bernard D¹,Baumgartner Helmut²,Delgado Victoria³,Gérard Olivier⁴,Haude Michael⁵,Himmelmann Anders⁶,Iung Bernard⁷,Leafstedt Matthew⁸,Lennartz Jasmine⁸,Maisano Francesco⁹,Marinelli Elena Andreassi¹⁰,Modine Thomas¹¹,Mueller Markus¹²,Redwood Simon R¹,Rörick Olaf¹³,Sahyoun Cherif¹⁴,Saillant Erika⁴,Søndergaard Lars¹⁵,Thoenes Martin¹⁶,Thomitzek Karen¹⁷,Tschernich Marion⁴,Vahanian Alec⁷,Wendler Olaf¹⁸,Zemke Evelyn Julia¹³,Bax Jeroen J³

Affiliation:

1. Department of Cardiology, St Thomas’ Hospital, Westminster Bridge Road, London, UK

2. Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany

3. Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, RC Leiden, The Netherlands

4. GE Healthcare, Chicago, IL, USA

5. Medical Clinic I, Städtische Kliniken Neuss, Neuss, Germany

6. Astra Zeneca R&D, Gothenburg, Sweden

7. AP-HP, Cardiology Department, Bichat Hospital, Paris-Diderot University, Paris, France

8. Medtronic, Tolochenaz, Switzerland

9. Klinik für Herz- und Gefässchirurgie, UniversitätsSpital Zürich, Zürich, Switzerland

10. Daiichi-Sankyo Europe GmbH, Munich, Germany

11. Department of Cardiovascular Surgery, Hopital Cardiologique CHRU de Lille, Lille, France

12. Pfizer Inc., Berlin, Germany

13. Siemens Healthineers, Erlangen, Germany

14. Philips Healthcare, Best, The Netherlands

15. Department of Cardiology, The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

16. Edwards Lifesciences, Nyon, Switzerland

17. Bayer AG, Berlin, Germany

18. Department of Cardiothoracic Surgery, King’s College Hospital, London, UK

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/40/5/422/27644279/ehy668.pdf

Reference96 articles.

1. 2017 ESC/EACTS guidelines for the management of valvular heart disease;Baumgartner;Eur Heart J,2017

2. The transcatheter valve technology pipeline for treatment of adult valvular heart disease;Figulla;Eur Heart J,2016

3. ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 appropriate use criteria for the treatment of patients with severe aortic stenosis: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons;Bonow;J Am Coll Cardiol,2017

4. Transcatheter aortic valve replacement 2016: a modern-day “Through the Looking-Glass” adventure;Vahl;J Am Coll Cardiol,2016

5. Educational needs and application of guidelines in the management of patients with mitral regurgitation. A European mixed-methods study;Iung;Eur Heart J,2018

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and Application of Comprehensive Management System For Patients with Chronic Aortic Valve Disease-A Perspective From West China Hospital;Current Problems in Cardiology;2024-01

2. A multifunctional soft robot for cardiac interventions;Science Advances;2023-10-27

3. Transcatheter interventions for left-sided valvular heart disease complicated by cardiogenic shock: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the Association for Acute Cardiovascular Care (ACVC) and the ESC Working Group on Cardiovascular Surgery;EuroIntervention;2023-10

4. The Chronic Systolic Heart Failure Patient: Presentation and Management;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

5. Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation;EuroIntervention;2023-09